MedTrace Logo

Developing and Evaluating Effectiveness of a Reinstatement Tutorial

NCT02056314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2018-05-14

No results posted yet for this study

Summary

This study will compare a computerized tutorial to a brochure in terms of their education impact of people who wish to end voluntary self-exclusion. Voluntary self-exclusion is a program used by people who seek to bar themselves from further access to the casino or other gambling venue. The Centre for Addiction and Mental Health (CAMH), in cooperation with Ontario Lottery and Gaming (OLG), is developing a tutorial designed to provide practical information to players who choose to reinstate and return to gambling. The goal of this study is to determine if this new computerized tutorial decreases the harm of gambling experienced by gamblers who are reinstated. For example, are they less likely to relapsing to problematic levels of gambling.

Conditions

  • Problem Gambling

Interventions

OTHER

electronic tutorial

The electronic tutorial will provide information to the participants about the nature of gambling, and how to protect themselves against the risks of problem gambling including information on coping skills, and myths associated with gambling.

OTHER

brochure

The brochure is the current means of informing people about the risks of problem gambling. It includes information about problem gambling and help resources.

Sponsors & Collaborators

  • Ontario Lottery and Gaming

    collaborator UNKNOWN

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Nigel E. Turner, Ph.D. · Centre for Addiction and Mental Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2018-01-31
Completion
2018-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056314 on ClinicalTrials.gov